Citrin et al., in 2012, demonstrated that salivary IL-6, IL-8, EGF, IL-4, TNF-α, VEGF, and monocyte chemoattractant protein-1 (MCP-1) could predict for chemoradiotherapy toxicity or tumor control [13]. This evidence concerns the gene CCL2 and neoplasm.